Linking Hospitalized Injection Drug Users to Buprenorphine



Status:Completed
Conditions:Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Psychiatry / Psychology
Healthy:No
Age Range:18 - 75
Updated:4/21/2016
Start Date:September 2009
End Date:September 2015

Use our guide to learn which trials are right for you!

This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization,
and then providing an appointment (a "link") for after discharge to maintenance
buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who
inject opioids.

In this randomized controlled trial, medically hospitalized opioid dependent patients will
be assigned to a "treatment as usual" group, where they will receive a detox regiment of
Suboxone during their hospital stay, or a "linkage" group, where they receive a maintenance
course of Suboxone during their hospital stay, and appointment post-discharge with an
outpatient Suboxone clinic/provider and a Suboxone prescription to use between discharge and
this appointment. Study interviews are completed at baseline, and 1, 3- and 6-months
post-baseline. Primary outcomes are opioid use and HIV risk behavior.

Inclusion Criteria:

- 18 years of age or older

- Current opioid injector, at least weekly in the past month

- Current opioid dependence, SCID confirmed

- Currently receiving an inpatient buprenorphine detoxification protocol.

Exclusion Criteria:

- Patients unable to be interviewed due to acute illness or cognitive impairment

- In police custody, expecting incarceration

- Persons who cannot provide two contact persons (including shelters, parole officers,
etc.) to verify location

- Not able to complete assessments in English

- Enrolled in a methadone maintenance program

- Plans to leave the area within the next 6 months.
We found this trial at
1
site
Boston, Massachusetts 02118
?
mi
from
Boston, MA
Click here to add this to my saved trials